India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:523489 has a market cap or net worth of INR 246.47 million. The enterprise value is 318.75 million.
| Market Cap | 246.47M |
| Enterprise Value | 318.75M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:523489 has 7.47 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 7.47M |
| Shares Outstanding | 7.47M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.59% |
| Owned by Insiders (%) | 62.76% |
| Owned by Institutions (%) | n/a |
| Float | 2.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | -13.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.97 |
| P/OCF Ratio | 11.34 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -23.20 |
| EV / Sales | 0.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 16.77 |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 5.59 |
| Interest Coverage | -1.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.77% |
| Return on Invested Capital (ROIC) | -8.63% |
| Return on Capital Employed (ROCE) | -13.30% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | -56,299 |
| Employee Count | 244 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 38.40 |
Taxes
| Income Tax | -544,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.48% in the last 52 weeks. The beta is 0.35, so BOM:523489's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -10.48% |
| 50-Day Moving Average | 33.25 |
| 200-Day Moving Average | 37.34 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 1,844 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:523489 had revenue of INR 348.19 million and -13.74 million in losses. Loss per share was -1.84.
| Revenue | 348.19M |
| Gross Profit | 187.78M |
| Operating Income | -13.68M |
| Pretax Income | -14.28M |
| Net Income | -13.74M |
| EBITDA | -2.05M |
| EBIT | -13.68M |
| Loss Per Share | -1.84 |
Balance Sheet
The company has 33.97 million in cash and 106.26 million in debt, giving a net cash position of -72.30 million or -9.68 per share.
| Cash & Cash Equivalents | 33.97M |
| Total Debt | 106.26M |
| Net Cash | -72.30M |
| Net Cash Per Share | -9.68 |
| Equity (Book Value) | -18.87M |
| Book Value Per Share | -2.53 |
| Working Capital | -57.29M |
Cash Flow
In the last 12 months, operating cash flow was 21.73 million and capital expenditures -2.73 million, giving a free cash flow of 19.01 million.
| Operating Cash Flow | 21.73M |
| Capital Expenditures | -2.73M |
| Free Cash Flow | 19.01M |
| FCF Per Share | 2.54 |
Margins
Gross margin is 53.93%, with operating and profit margins of -3.93% and -3.95%.
| Gross Margin | 53.93% |
| Operating Margin | -3.93% |
| Pretax Margin | -4.10% |
| Profit Margin | -3.95% |
| EBITDA Margin | -0.59% |
| EBIT Margin | -3.93% |
| FCF Margin | 5.46% |
Dividends & Yields
BOM:523489 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.57% |
| FCF Yield | 7.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |